Argenx cut to Sell at Deutsche Bank on valuation
by
Contributor since / Followers
Contributor since / Followers
15 hours ago
Pgiam/iStock via Getty Images
Deutsche Bank downgraded argenx (NASDAQ:ARGX) to Sell from Hold on Friday, citing a “clearly unfavorable” valuation setup despite the Dutch biotech’s promising preliminary net sales results for Q4 2024 this week.
On Monday, citing unaudited data, argenx (NASDAQ:ARGX) reported $737M